In-vitro activities of 16 non-β-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 4, 1999, Pages 563-567

  Verhaegen, J ^a   Verbist, L ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CLINAFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE; TROVAFLOXACIN;

ARTICLE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0032947223     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.4.563     Document Type: Article

References (8)

1. Verhaegen, J. & Verbist, L. (1998). In-vitro activity of 21 β-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 41, 381-5.
2. National Committee for Clinical Laboratory Standards. (1998). Performance Standards for Antimicrobial Susceptibility Testing - Eighth Informational Supplement: Approved Standard M100-S8. NCCLS, Wayne, PA.
3. Ednie, L. M., Visalli, M. A., Jacobs, M. R. & Appelbaum, P. C. (1996). Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. Antimicrobial Agents and Chemotherapy 40, 1950-2.
4. Visalli, M. A., Jacobs, M. R. & Appelbaum, P. C. (1997). Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin. Antimicrobial Agents and Chemotherapy 41, 1867-70.
5. Leclercq, R. & Courvalin, P. (1993). Resistance to macrolides, azalides and streptogramins. In The New Macrolides, Azalides, and Streptogramins: Pharmacology and Clinical Applications (Neu, H. C., Young, S. S. & Zinner, S. H., Eds), p. 33-40. Marcel Dekker, New York.
6. Fuchs, P. C., Barry, A. L. & Brown, S. D. (1996). Tentative interpretive criteria for testing the susceptibility of Streptococcus pneumoniae to eight fluoroquinolones. Diagnostic Microbiology and Infectious Disease 26, 23-7.
7. Knudsen, J. D., Fuursted, K., Espersen, F. & Frimodt-Moller, N. (1997). Activities of vancomycin and teicoplanin against penicillin-resistant pneumococci in vitro and in vivo and correlation to pharmacokinetic parameters in the mouse peritonitis model. Antimicrobial Agents and Chemotherapy 41, 1910-5.
8. Schwalbe, R. S., McIntosh, A. C., Qaiyumi, S., Johnson, J. A., Johnson, R. J., Furness, K. M. et al. (1996). In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci. Antimicrobial Agents and Chemotherapy 40, 2416-9.